Navigation Links
Drugs.com Releases Q4 Sales for Top 100 U.S. Drugs
Date:2/13/2013

NEW YORK, Feb. 13, 2013 /PRNewswire/ -- Drugs.com, the leading online clinical drug resource, today released fourth quarter 2012 U.S. prescription sales data for the top 100 drugs.

At the close of 2012, Otsuka's antipsychotic Abilify overtakes AstraZeneca's acid reducer Nexium and moves into the number one spot with over $1.47 billion in quarterly sales. Sales expanded for all five front-runners over the quarter, although none reached double-digit growth. There are no changes in the top selling pharmaceutical classes, which include antipsychotics, proton pump inhibitors, and statins.Top Five Drugs by Sales, Q4 2012Drug Name  

Gain ($000)  

% Change (previous quarter)budesonide$79,295

+42.52%Abilify$73,075

+5.20%Cymbalta$69,131

+5.97%Lantus Solostar

$62,028

+11.58%Advair Diskus$56,263

+4.90%Top Five Sales Losses, Q4 2012Drug Name

Gain ($000)% Change (previous quarter)TriCor-$128,731

-41.58%Neulasta-$29,497

-3.54%Incivek-$26,778

-9.14%One Touch Ultra

-$24,687

-6.59%Avonex-$20,275

-5.17%AbbVie's cholesterol treatment TriCor drops 53 spots with a $129 million sales decline in Q4 2012 even though it did not lose patent protection until January of 2013. Neulasta, Incivek and Avonex also report declining sales of $20 to $30 million.

"The top five brands maintained their leading positions in the last quarter of 2012." said Philip Thornton , CEO of Drugs.com. "Fewer blockbuster brands lost exclusivity, however 2013 will bring a new round of generic competition highlighted by the expected Cymbalta patent loss later this year."

Zomig and Aciphex are additional top-selling brands expected to lose patent protection in 2013.

Detailed data on the top 100 drugs can be accessed at: 
http://www.drugs.com/stats/top100/sales

About Drugs.com

Drugs.com is the leading online drug information resource with over nine million unique visitors per month (ComScore, January 2013). Providing free, independent, peer-reviewed, and up-to-date information at both consumer and professional levels, Drugs.com empowers patients and caregivers to take charge of their health and be more informed than ever before. The site includes many interactive tools and mobile apps to assist consumers, healthcare professionals and researchers, such as personal medication records, a drug interaction checker, pill identification wizard, symptom checker, pharma sales statistics and more.

For more information, visit: www.drugs.com

Media Inquiries: 
Drugs.com Press Officer 
press@drugs.com 
(718) 395 2473

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.

 


'/>"/>
SOURCE Drugs.com
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Latest Drug Sales Data: Loss of Patent Protection Has Significant Effect, According to Drugs.com
2. Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But Nexium and Abilify Remain the Leading Brands
3. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
4. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
5. ShelfX Releases A Fridge That Knows What You Took
6. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
7. Stereotaxis Releases V-Sono™ Intracardiac Echocardiography Module for the Vdrive™ Remote Navigation System
8. Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events
9. Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial
10. MD Bioproducts releases HLA-B27 subtype specific antibody.
11. ChemDAQ Releases First Sensor For Detection Of Peracetic Acid In Air
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016 The primary goal ... future adoption patterns on the usage of liquid biopsy. ... following: - Timeframe of liquid biopsy adoption ... cfDNA and Evs—by organization type - Sample inflow to ... blood, saliva, stool, serum, and so on. - Correlation ...
(Date:2/11/2016)... 2016 PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial ... 2015. The Company also filed its Quarterly Report on Form ... the Securities and Exchange Commission today. --> ... --> --> Net sales for ... or 95%, to $5.4 million from $2.8 million for the ...
(Date:2/11/2016)... , Feb. 11, 2016  Kindred Biosciences, Inc. ... saving and improving the lives of pets, today announced ... of the New Animal Drug Application (NADA) for Zimeta™ ... field study (KB0120) of Zimeta for the control of ... Company. --> --> ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... The ThedaCare ... San Francisco General Hospital on April 5-7. The series is a multi-day, multi-workshop ... habits. The workshops cover a broad range of topics, including coaching skills, the ...
(Date:2/12/2016)... ... 2016 , ... Fisher House Foundation Chairman and CEO Kenneth Fisher joined Governor ... Alliance president Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare System yesterday ... This will be the first Fisher House in Nevada, and will provide free lodging ...
(Date:2/12/2016)... ... ... Vail knee specialist Robert LaPrade, MD, PhD was named one of ... of physicians establishing, leading and partnering with ambulatory surgery centers across the United States. ... also known as an ASC, is a modern health care facility focused on providing ...
(Date:2/12/2016)... ... ... Donor Network West, the organ procurement organization that heals lives through organ ... Regional Medical Center. Under the collaboration, the first of its kind, specific organ donors ... certain time frame for donor families for the recovery of organs. , Organ ...
(Date:2/12/2016)... ... 12, 2016 , ... J Thomas & Associates Insurance Agency, ... to act as Agents of Change in the community, announces a new partnership ... to fulfill immediate needs and help them move into permanent housing. Donations to ...
Breaking Medicine News(10 mins):